Fundraising FoxFormation Group — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)William S. Marth, RPh., MBA(President & CEO)
BoardRobert Nelsen(Chairman, Resilience; Founder, ARCH)
Co-investors8VCARCH Venture PartnersCatalio Capital Management, LPGlobal Health Investment CorporationGV (Google Ventures)Koch Disruptive Technologies+13 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.